Global Automated Breast Ultrasound System Market Strategic Research Report

Scope of the Report

The global Automated Breast Ultrasound System market size is predicted to grow from US$ 626 million in 2025 to US$ 1,362 million in 2032; it is expected to grow at a CAGR of 11.7% from 2026 to 2032.

An Automated Breast Ultrasound System is a dedicated medical imaging platform that uses a mechanical scanning mechanism, wide-aperture volumetric transducer, robotic arm, or circular ultrasound array to acquire standardized and reproducible images of the entire breast or a defined breast volume. The system generally produces continuous two-dimensional images or three-dimensional volumetric datasets and may incorporate coronal, transverse, and sagittal reconstruction, lesion localization, image-quality assessment, longitudinal comparison, and AI-assisted interpretation.

Automated breast ultrasound is primarily used as a supplemental examination following mammography in women with dense breast tissue. It can also support diagnostic assessment, treatment-response monitoring, and population-based breast screening. Commercial ABUS systems are generally positioned as adjuncts to mammography rather than direct replacements for mammographic screening. In 2025, global shipments of Automated Breast Ultrasound Systems are estimated at approximately 3,200 sets, with an average price of approximately US$190,000 per set and a gross margin of approximately 42% to 55%.

The global burden of breast cancer, increasing awareness of dense breast tissue, and shortages of experienced sonographers are the principal growth drivers for Automated Breast Ultrasound Systems. Automated acquisition separates image capture from physician interpretation, improves reproducibility, and supports centralized or remote reading. These characteristics make the technology particularly suitable for breast centers, diagnostic imaging facilities, health-screening organizations, and institutions operating multiple screening locations.

Market adoption nevertheless remains constrained by clinical evidence, reimbursement, and operating economics. Current evidence is insufficient to establish the overall balance of benefits and harms of supplemental ultrasound screening for every woman with dense breasts and a normal mammogram. Supplemental ultrasound can also increase false-positive recalls and biopsies. High acquisition costs, inconsistent reimbursement, radiologist training requirements, and the need to integrate ABUS datasets with existing PACS and mammography workflows can extend the investment payback period.

Future demand will develop along three principal paths. Mature markets will continue to focus on supplemental screening for women with dense breasts, supported by AI-based quality control, computer-aided lesion detection, and longitudinal comparison. China and other Asian markets will increasingly deploy lower-cost automated systems in health-screening centers, population-screening programs, and primary-care networks. Breast ultrasound tomography, autonomous robotic scanning, and portable or wearable automated acquisition will create additional premium and decentralized market segments as their regulatory approvals and clinical evidence expand.

This report presents a comprehensive overview of the global Automated Breast Ultrasound System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Automated Wide-Field Compression Scanner
• Mechanically Guided Linear Sweep System
• Robotic Arm Scanning System
• Others

Segment by System Configuration

• Dedicated Standalone ABUS
• General Ultrasound With ABVS Module
• Integrated Breast Ultrasound Platform
• Others

Segment by Imaging Technology

• Three-Dimensional Volumetric Ultrasound
• Two-Dimensional Automated Cine Ultrasound
• Multimodal Breast Ultrasound
• Others

Segment by Application

• Hospitals And Breast Centers
• Diagnostic Imaging Centers
• Health Screening Centers
• Mobile And Primary Care Programs
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Automated Breast Ultrasound System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals And Breast Centers, Diagnostic Imaging Centers, Health Screening Centers evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact